Abstract:BACKGROUND:Tetralogy of Fallot (TOF) is a common congenital heart disease (CHD) but the impact of the variants of the HAND1 gene promoter region has not been explored. METHODS:DNA from blood samples of 612 subjects (300 sporadic TOF patients and 312 healthy controls) was sequenced to identify variants in the HAND1 gene promoter region that were further tested by cellular function experiments including dual-luciferase reporter gene assays, electrophoretic mobility shift analysis (EMSA), and bioinformatics analysis using JASPAR, a transcription factor binding site database. RESULTS:Eight variants in HAND1 gene promoter region were identified with 3 only found in TOF patients including one novel g.3639 G > T. All 3 variants significantly reduced the transcriptional activity of HAND1 gene promoter in an in vitro reporter assay (p < 0.05). JASPAR analysis indicated that these variants may alter the binding sites of transcription factors, potentially associated with TOF formation. CONCLUSIONS:In the promoter region of HAND1gene of TOF patients, 3 variants were found only in the patients including one found for the first time. These variants decreased transcription factor activity. Therefore, the present study implies the role of HAND1 gene in the pathogenesis of TOF and further provides new insights into the genetic basis of TOF formation. IMPACT:Sequencing of DNA from 612 human subjects (300 TOF patients and 312 healthy controls) identified 8 variants in the promoter region of HAND1 gene with 3 found only in TOF including 1 newly identified. Reduced transcriptional activity at these 3 variants was confirmed by dual-luciferase reporter gene assay and EMSA assay. Predictions from the JASPAR database suggest altered binding sites of transcription factors by the variants. We for the first time demonstrate variants in the HAND1 promoter and that cause cellular dysfunction. The variants identified may have a pathological role in the formation of TOF.

Somatic Mutations in the GATA6 Gene Underlie Sporadic Tetralogy of Fallot

Somatic Gata5 Mutations In Sporadic Tetralogy Of Fallot

Somatic GATA4 mutation contributes to tetralogy of Fallot

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

GATA4 loss-of-function mutations underlie familial tetralogy of fallot.

Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot.

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

Identification of two novel GATA6 mutations in patients with nonsyndromic conotruncal heart defects.

Tetralogy of Fallot: Variants of MYH6 Gene Promoter and Cellular Functional Analyses

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

Targeted Sequencing Identifies Novel GATA6 Variants in a Large Cohort of Patients with Conotruncal Heart Defects.

DNA Sequencing of TGFβ2 in Sporadic Patients with Tetralogy of Fallot.

Identification and Functional Validation of Variants in the Promoter Region of HAND1 Gene in Sporadic Tetralogy of Fallot

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification

Genetic Variants of ISL1 Gene Promoter Identified from Congenital Tetralogy of Fallot Patients Alter Cellular Function Forming Disease Basis